AstraZeneca acknowledges for the first time that its vaccines have caused serious side effect

The British group AstraZeneca has for the first time admitted to court that some of its vaccines against Cavido cause fatal blood clots in the veins.

The local Daily Mail network, writes that the rare side effect is at the centre of a multi-million-million-euro payback indictment by British citizens who have been crippled or lost their relatives by the pharmaceutical giant's ʹdefectious vaccines.

Cambridge-based company AstraZeneca, which disputes claims, has agreed to documents submitted in February if rare cases cause fatal blood clots known in Britain as TTS (trombos with trumpet-cypenia symptoms).

This complication listed as a side effect of the vaccine is previously labeled as “trombo-cytopen driven by vaccine”. Acceptance made by AstraZeneca may already lead to individual reparations of any case, the Daily Mail writes.

Development comes as the company announced profits of 10 billion pounds in only 2024.

One of those seeking compensation is father to two children, engineer I T, Jamie Scott, who has been disabled by permanent brain injuries after taking the vaccine in April 2021.

It is one of 51 cases of the indictment, estimated to reach 100 million pounds.

His wife, Kate Scott, said: “I hope this admission brings a solution now, even though it's late. We ask to apologize, to provide compensation for us and other affected families, we do not give up. ”

New documents showed a change in language used by AstraZeneca in past sessions, when the company insisted that the heavy side effect could not have been caused by their vaccine “at the genetic level”.

Health officials have identified cases of effect on blood by AstraZeneca vaccine in Europe since March 2021, just two months after the release of vaccines on the market.

By April the evidence became clear and the vaccine began to be limited, media wrote.

About 50 million doses of AstraZeneca have been injected to Britain in total.